• Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

  • Oct 25 2024
  • Length: 10 mins
  • Podcast

Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

Listen for free

View show details

  • Summary

  • Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available